Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001159036-25-000034
Filing Date
2025-08-05
Accepted
2025-08-05 16:09:53
Documents
80
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q halo-20250630.htm   iXBRL 10-Q 1497131
2 EX-31.1 ex31110qq22025.htm EX-31.1 12749
3 EX-31.2 ex31210qq22025.htm EX-31.2 12689
4 EX-32 ex3210qq22025.htm EX-32 13675
10 GRAPHIC halo-20250630_g1.jpg GRAPHIC 15840
11 GRAPHIC halo-20250630_g2.jpg GRAPHIC 2463193
12 GRAPHIC halo-20250630_g3.jpg GRAPHIC 594283
  Complete submission text file 0001159036-25-000034.txt   15429231

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT halo-20250630.xsd EX-101.SCH 50757
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT halo-20250630_cal.xml EX-101.CAL 80352
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT halo-20250630_def.xml EX-101.DEF 259060
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT halo-20250630_lab.xml EX-101.LAB 677529
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT halo-20250630_pre.xml EX-101.PRE 464769
83 EXTRACTED XBRL INSTANCE DOCUMENT halo-20250630_htm.xml XML 1333082
Mailing Address 12390 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12390 EL CAMINO REAL SAN DIEGO CA 92130 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Filer) CIK: 0001159036 (see all company filings)

EIN.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32335 | Film No.: 251185043
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)